Toyota Motor and Sony led Japanese firms that set up a new company named Rapidus to ramp up next-generation semiconductor production.
The consortium also includes SoftBank Corp, Nippon Telegraph and Telephone Corp, Kioxia Corp, Denso Corp, NEC Corp, and MUFG Bank.
The eight firms will invest around 7 billion yen in the consortium, while the Japanese government will extend 70 billion yen in subsidies.
Rapidus will develop and manufacture chips and advance the cultivation of human resources in the semiconductor industry.
Rapidus is aiming to develop and produce sub-2-nanometer semiconductors by the late 2020s.
The joint effort by the consortium comes amid intensifying global competition to develop advanced chips to be used in quantum computers, artificial intelligence, and military weapons.
The move also coincides with a worldwide chip shortage and spurred concerns about Japan’s economic security as the race has been led by companies in Taiwan, South Korea, and the US.


China's Push to Steal Taiwan's Chip Technology and Talent Raises Security Alarms
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Global Markets Waver as U.S.-Iran War Deadline Looms and Oil Prices Surge
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
US Dollar Dips as Iran Rejects Ceasefire Amid Rising Middle East Tensions
Trump's FY2027 Budget: Major Defense Boost and Domestic Spending Cuts
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Gold Prices Slip in Asia as Iran Strait Deadline Looms
Morgan Stanley: Fed Rate Cuts Still on Track Despite Oil-Driven Inflation
Energy Prices and Dollar Climb as U.S.-Iran Conflict Grips Global Markets
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



